Development of a TRK-Targeting Degrader for Cancer & Pain Indications
Download the Full Event Guide for Full Session Details.
- Discovery of a potent and selective pan-TRK degrader
- Presenting preclinical validation of the TRK degrader in cancer models
- Presenting preclinical validation of the TRK degrader in pain models